Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Chang

Showing results (201-210 of 489) with videos related to

Pageof 49
Sort By:
The Journal of Urology|September 16, 2016
Re: Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor after Transurethral Resection for Bladder CancerSam S Chang
The Journal of Urology|September 16, 2016
Re: Development and External Validation of a Prognostic Tool for Prediction of Cancer-Specific Mortality after Complete Loco-Regional Pathological Staging for Squamous Cell Carcinoma of the PenisSam S Chang
The Journal of Urology|September 7, 2016
Re: Usefulness of pT1 Substaging in Papillary Urothelial Bladder CarcinomaSam S Chang
The Journal of Urology|September 7, 2016
Re: Racial and Economic Disparities in the Treatment of Penile Squamous Cell Carcinoma: Results from the National Cancer DatabaseSam S Chang
The Journal of Urology|May 17, 2017
Re: The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical CystectomySam S Chang
The Journal of Urology|April 22, 2018
Re: Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results from a Phase 1/2 Open-Label StudySam S Chang
The Journal of Urology|April 13, 2018
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node InvolvementSam S Chang
Nature Clinical Practice. Urology|June 10, 2006
The adverse consequences of delaying radical cystectomySam S Chang
Postgraduate Medicine|November 21, 2008
Solifenacin at 3 years: a review of efficacy and safety. CommentarySam S Chang
The Journal of Urology|November 20, 2015
Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial CarcinomaSam S Chang
Pageof 49

Showing results (201-210 of 489) with videos related to

Sort By:
Pageof 49
The Journal of Urology|September 16, 2016
Re: Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor after Transurethral Resection for Bladder CancerSam S Chang
The Journal of Urology|September 16, 2016
Re: Development and External Validation of a Prognostic Tool for Prediction of Cancer-Specific Mortality after Complete Loco-Regional Pathological Staging for Squamous Cell Carcinoma of the PenisSam S Chang
The Journal of Urology|September 7, 2016
Re: Usefulness of pT1 Substaging in Papillary Urothelial Bladder CarcinomaSam S Chang
The Journal of Urology|September 7, 2016
Re: Racial and Economic Disparities in the Treatment of Penile Squamous Cell Carcinoma: Results from the National Cancer DatabaseSam S Chang
The Journal of Urology|May 17, 2017
Re: The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical CystectomySam S Chang
The Journal of Urology|April 22, 2018
Re: Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results from a Phase 1/2 Open-Label StudySam S Chang
The Journal of Urology|April 13, 2018
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node InvolvementSam S Chang
Nature Clinical Practice. Urology|June 10, 2006
The adverse consequences of delaying radical cystectomySam S Chang
Postgraduate Medicine|November 21, 2008
Solifenacin at 3 years: a review of efficacy and safety. CommentarySam S Chang
The Journal of Urology|November 20, 2015
Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial CarcinomaSam S Chang
Pageof 49